Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-06FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Olanzapine by Macleods Pharmaceuticals Limited, supporting a generic version of the drug.
-
FDA approval · 2026-01-05FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from BluePoint Laboratories. This approval supports the continued authoriz…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness [NA]
ClinicalTrials.gov update indicates the study 'Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness' is …
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder [Phase 4]
Phase 4 trial evaluating tachyphylaxis, tolerance, and withdrawal after treatment with intranasal dexmedetomidine (Igalmi) for agitation in …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant Aggression [NA]
A clinical trial update describes using deep brain stimulation to treat severe, resistant aggression in individuals with autism spectrum dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia [NA]
This clinical trial update notes the completion of a study evaluating social cognition in youth who have a first-degree relative with schizo…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. [Phase 3]
Phase 3 trial results detailing the long-term safety and tolerability of an investigational drug in adults with schizophrenia.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: KetoBrain: Brain Energy Metabolism in Schizophrenia
A clinical trial called KetoBrain is investigating brain energy metabolism in people with schizophrenia and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Exercise Therapy in Mental Disorders-study [NA]
A clinical trial at Haukeland University Hospital is currently recruiting to evaluate the effects of exercise therapy in individuals with sc…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Mindfulness Psychoeducation for Schizophrenia [NA]
A clinical trial evaluating mindfulness-based psychoeducation for schizophrenia has been completed.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Personalized iTBS in Real-World Clinical Settings for Schizophrenia [NA]
Recruitment is ongoing for a real-world study evaluating personalized intermittent theta-burst stimulation (iTBS) as a treatment for schizop…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life
A clinical trial update shows that Çankırı Karatekin University is recruiting for a study examining how schizophrenia and bipolar disorder a…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Taking Action for College Students [NA]
Temple University is recruiting for a clinical trial studying major depressive disorder, bipolar disorder, and schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Multimodal MRI-guided rTMS to Treat Refractory Hallucinations [NA]
A completed clinical trial evaluated multimodal MRI-guided repetitive transcranial magnetic stimulation (rTMS) for treating refractory hallu…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability and pharmacokinetics of multiple ascending doses of VV119 in schizophrenia; study cur…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness [NA]
This update reports the completion of a VA-sponsored clinical trial evaluating collaborative decision skills training for veterans with seri…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study of ALTO-101 in Patients With Schizophrenia [Phase 2]
ALTO-101 is being studied in a Phase 2 trial for schizophrenia with cognitive impairment, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Academic-Community EPINET (AC-EPINET) [NA]
Clinical trial update for the Academic-Community EPINET (AC-EPINET) study led by Indiana University; the trial status is completed and it in…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Mobile Thinking Intervention: A Inital Test [NA]
This clinical trial update describes a preliminary test of a mobile thinking intervention for individuals with schizophrenia and those at cl…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia [Phase 1]
A Phase 1 clinical trial evaluating the dose levels, safety, and drug levels after a single intramuscular injection of KarXT in participants…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Testing Effect and Schizophrenia [NA]
A completed clinical trial from Strasbourg investigating effects related to schizophrenia with episodic memory deficits.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Autobiographical Memory Organization in Schizophrenia [NA]
A completed clinical trial from University Hospital Strasbourg evaluating autobiographical memory organization in individuals with schizophr…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders [NA]
This clinical trial update describes a study characterizing high-level cognitive impairments in patients with neuropsychiatric disorders, wh…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia [NA]
The STIM'ZO trial evaluating transcranial direct current stimulation (tDCS) as an add-on treatment for persistent symptoms in schizophrenia …
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Metformin Treatment on Cognitive Impairment of Schizophrenia [Phase 3]
A Phase 3 clinical trial in China is investigating metformin for cognitive impairment in schizophrenia and is currently recruiting.